ACADIA Pharmaceuticals Inc (ACAD)
14.79
-0.06
(-0.40%)
USD |
NASDAQ |
May 17, 16:00
14.78
-0.02
(-0.10%)
After-Hours: 20:00
ACADIA Pharmaceuticals Gross Profit (TTM): 750.88M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 750.88M |
December 31, 2023 | 684.80M |
September 30, 2023 | 605.72M |
June 30, 2023 | 537.23M |
March 31, 2023 | 511.35M |
December 31, 2022 | 507.07M |
September 30, 2022 | 501.19M |
June 30, 2022 | 497.54M |
March 31, 2022 | 475.66M |
December 31, 2021 | 465.00M |
September 30, 2021 | 452.51M |
June 30, 2021 | 443.36M |
March 31, 2021 | 437.97M |
December 31, 2020 | 421.20M |
September 30, 2020 | 398.49M |
June 30, 2020 | 372.61M |
March 31, 2020 | 346.19M |
December 31, 2019 | 319.48M |
September 30, 2019 | 281.66M |
June 30, 2019 | 244.70M |
March 31, 2019 | 218.47M |
December 31, 2018 | 205.48M |
September 30, 2018 | 190.16M |
June 30, 2018 | 169.59M |
March 31, 2018 | 144.88M |
Date | Value |
---|---|
December 31, 2017 | 111.84M |
September 30, 2017 | 81.63M |
June 30, 2017 | 53.22M |
March 31, 2017 | 25.27M |
December 31, 2016 | 12.92M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
244.70M
Minimum
Jun 2019
750.88M
Maximum
Mar 2024
462.73M
Average
458.76M
Median
Gross Profit (TTM) Benchmarks
Regulus Therapeutics Inc | -- |
Amylyx Pharmaceuticals Inc | 261.44M |
Alnylam Pharmaceuticals Inc | 1.682B |
Cassava Sciences Inc | -- |
Oragenics Inc | -- |